Zo plastisch is ons zenuwstelsel

Aloe, L. Bracci Laudiero, L., Alleva, E., Lambiase, A., Micera, A., Tirassa, P. (1994): Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91, 10440–10444. Anonymous (1996): A double–blind placebo–controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rhcntf) in amyotrophic lateral sclerosis. Neurology 46, 1244–1249. Ebadi, M., Bashir, R.M., Heidrick, M.L., Hamada, F.M., El Refaey, H., Hamed, A., Helal, G., Baxi, M.D., Cerutis, D.R., Lassi, N.K. (1997): Neurotrophins and their receptors in nerve injury and repair (review). Neurochem.Int. 30, 347–374. Fisher, L.J. (1997): Neural Precursor Cells: Applications for the Study and Repair of the Central Nervous System. Neurobiology of Diseases 4, 1–22. Hefti, F. (1994): Neurotrophic Factor Therapy for Nervous System Degenerative Diseases. J. Neurobiol. 25, 1418–1435. Hefti, F. (1997): Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol. Toxicol. 37, Hoffner, B., Olson, L. (1997): Treatment strategies for neurodegenerative diseases based on trophic factors and cell transplantation techniques. J. Neural. Transm.[suppl] 49, 1–10. Knusel, B., Gao, H. (1996): Neurotrophins and Alzheimer=s Disease: Beyond the Cholinergic Neurons. Life Sciences 58, 2019–2027. Leeuwen, F.W. van, Kleijn, D.P.V. de, Hurk, H.H.van den, Neubauer, A., Sonnemans, M.A.F., Sluijs, J.A., Köycü, s., Ramdjielal, R.D.J., Salehi, A., Martens, G.J.M., Grosveld, F.G., Burbach, J.P.H., Hol; E.M. (1998): Frameshift Mutants of · β–Amyloid Precursor Protein and Ubiquitin–B in Alzheimer's and Down Patients. Science 279, 242–247. Levi–Montalcini, R. (1987): The Nerve Growth Factor 35 Years Later, Science 237, 1154–1162. Lindholm, D. (1997): Models to study the role of neurotrophic factors in neurodegeneration. J. Neural. Transm.[suppl] 49, 33–42. Louvel, E., Hugon, J., Doble, A. (1997): Therapeutic advances in amyotrophic lateral sclerosis. Trends in Pharmacological Sciences 18, 196–203. Miller, R.G., Petajan, J.H., Bryan, W.W., Armon, C., Barohn, R.J., Goodpasture, J.C., Hoagland, R.J., Parry, G.J., Olson, L. (1993): ngf and the Treatment of Alzheimer's Disease. Exp. Neurol. 124, 5–15. Shen, L., Figurov, A., Lu, B. (1997): Recent progress in studies of neurotrophic factors and their clinical implications. J.Mol.Med. 75, 637–644. Petty, B.G., Cornblath, D.R., Adornato, B.T., Chaudhry, V., Flexner, C., Wachsman, M., Sinicropi, D., Burton, L.E., Peroutka, S.J. (1994): The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann.Neurol. 36, 244–246. Ross, M.A., Stromatt, S.C. (1996): A placebo–controlled trial of recombinant human ciliary neurotrophic (rhcntf) factor in amyotrophic lateral sclerosis. Ann.Neurol. 39, 256–260. Salehi, A., Verhaagen, J., Dijkhuizen, P.A., Swaab, D.F. (1996): Co–localization of high–affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer=s Disease. Neuroscience 75, 373–387. Thoenen, H. (1995): Neurotrophins and neuronal plasticity. Science 270, 593–596.